Stevens Capital Management’s Celgene Corp CELG Stock Holding History

Stevens Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-174,944	Closed	-$11.2M	–	991
2018 Q4	$11.2M	Buy	174,944 +39,196	+29%	+$2.89M	0.58%	30
2018 Q3	$12.1M	Buy	135,748 +12,784	+10%	+$1.13M	0.44%	61
2018 Q2	$9.77M	Buy	+122,964	New	+$10.2M	0.35%	78
2016 Q4	–	Sell	-233,961	Closed	-$24.5M	–	1257
2016 Q3	$24.5M	Buy	233,961 +217,706	+1,339%	+$23.6M	1.02%	9
2016 Q2	$1.6M	Buy	+16,255	New	+$1.68M	0.06%	339
2015 Q4	–	Sell	-5,140	Closed	-$556K	–	1338
2015 Q3	$556K	Buy	+5,140	New	+$638K	0.03%	506
2015 Q2	–	Sell	-358,257	Closed	-$41.3M	–	1414
2015 Q1	$41.3M	Buy	+358,257	New	+$42.8M	1.47%	4
2014 Q2	–	Sell	-590,798	Closed	-$41.2M	–	1526
2014 Q1	$41.2M	Buy	590,798 +558,094	+1,707%	+$44.2M	1.12%	3
2013 Q4	$2.76M	Buy	+32,704	New	+$2.59M	0.08%	280

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stevens Capital Management's CELG Position: Q1 2019 in Review

Stevens Capital Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 174,944 shares — an estimated $11.2M sold.

Stevens Capital Management first reported a position in CELG in Q4 2013 and held it in 9 quarters. The position peaked at $41.3M in Q1 2015. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

Stevens Capital Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
Stevens Capital Management sold 174,944 Celgene Corp shares in Q1 2019, an estimated $11.2M.
Stevens Capital Management first reported a position in Celgene Corp in Q4 2013 and held it in 9 quarters.
Stevens Capital Management's Celgene Corp position peaked at $41.3M in Q1 2015.
1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Stevens Capital Management's 13F filing for Q1 2019, filed 3 May 2019.